GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CollPlant Biotechnologies Ltd (NAS:CLGN) » Definitions » 6-1 Month Momentum %

CollPlant Biotechnologies (CollPlant Biotechnologies) 6-1 Month Momentum % : -20.78% (As of May. 01, 2024)


View and export this data going back to 2021. Start your Free Trial

What is CollPlant Biotechnologies 6-1 Month Momentum %?

6-1 Month Momentum % is the total return of the stock from 6-month ago to 1-month ago. As of today (2024-05-01), CollPlant Biotechnologies's 6-1 Month Momentum % is -20.78%.

The industry rank for CollPlant Biotechnologies's 6-1 Month Momentum % or its related term are showing as below:

CLGN's 6-1 Month Momentum % is not ranked
in the Biotechnology industry.
Industry Median: 4.14 vs CLGN: -20.78

Competitive Comparison of CollPlant Biotechnologies's 6-1 Month Momentum %

For the Biotechnology subindustry, CollPlant Biotechnologies's 6-1 Month Momentum %, along with its competitors' market caps and 6-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CollPlant Biotechnologies's 6-1 Month Momentum % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, CollPlant Biotechnologies's 6-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where CollPlant Biotechnologies's 6-1 Month Momentum % falls into.



CollPlant Biotechnologies  (NAS:CLGN) 6-1 Month Momentum % Calculation

6-1 Month Momentum % is calculated as following:

6-1 Month Momentum %=( Price 1-month ago / Price 6-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CollPlant Biotechnologies  (NAS:CLGN) 6-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 6-1 Month Momentum % measures the total return to a stock over the past six months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.


CollPlant Biotechnologies 6-1 Month Momentum % Related Terms

Thank you for viewing the detailed overview of CollPlant Biotechnologies's 6-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.


CollPlant Biotechnologies (CollPlant Biotechnologies) Business Description

Traded in Other Exchanges
Address
4 Oppenheimer Street, P.O. Box 4132, Weizmann Science Park, Rehovot, ISR, 7670104
CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The company's revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing.

CollPlant Biotechnologies (CollPlant Biotechnologies) Headlines